In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi

Medical Mycology

Volumn 36, Issue 4, 1998, Pages 243-246

  McGinnis, M R ^a   Pasarell, L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dematiaceous fungi; Itraconazole; Susceptibility testing; Terbinafine

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ASCOMYCETES; CANDIDA; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; SHORT SURVEY; STANDARD; TECHNIQUE;

ANTIFUNGAL AGENTS; ASCOMYCOTA; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES;

ASCOMYCOTA; CANDIDA; FUNGI;

EID: 33746441487     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1998.00154.x     Document Type: Short Survey

References (16)

1. Naka W. Treatment of chromomycosis. Jpn J Med Mycol 1966; 37: 147-51.
2. Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol 1994; 31: S91-S102.
3. Queiroz-Telles F, Purim KS, Fillus JN et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 1992; 31: 805-12.
4. Kullavanijakya P, Rojanavanich V. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 1995; 34: 804-7.
5. Esterre P, Andriantsimahavandy A, Ramarcel ER, Pecarrere J. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg 1996; 55: 45-7.
6. Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996; 134: Suppl. 46, 33-6.
7. Wong PK, Ching WTW, Kwon-Chung KJ, Meyer RD. Disseminated Phialophora parasitica infection in humans: case report and review. Rev Infect Dis 1989; 11: 770-5.
8. Bryan CS, Smith CW, Berg DE, Karp RB. Curvularia lunata endocarditis treated with terbinafine: case report. Clin Infect Dis 1993; 16: 30-2.
9. Esterre P. Ratsioharana M, Roig P. Potential use of terbinafine in the treatment of chromoblastomycosis. Rev Contemp Pharmacother 1997; 8: 357-61.
10. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. Villanova, PA: NCCLS, 1997.
11. Abdel-Rahman SM, Nahata MC. Oral terbinafine: a new antifungal agent. Ann Pharmacother 1997; 31: 445-56.
12. Greer DL, Hay RJ. Itraconazole Monograph. Adis International, Chester, UK, 1994.
13. Van Cutsem J. An investigation of the in vitro activity and antifungal spectrum of itraconazole and terbinafine in relation with in vivo efficacy in dermatophytosis and other mycoses. J Mycol Méd 1994; 4: 137-44.
14. Weete JD. Structure and function of sterols in fungi. Adv Lipid Res 1989; 23: 115-67.
15. Weete JD, Gandhi SR. Sterols of the phylum Zygomycota: phylogenetic implications. Lipids 1997; 32: 1309-16.
16. Clayton YM. The in vitro activity of terbinafine against uncommon fungal pathogens. In: Fromtling RA, ed. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona: J. R. Prous Science Publishers, 1987, 433-9.